Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
acetylcysteine (mucomyst) (1 trial)
Cognitive Dysfunction (Phase 1)
Schizophrenia (Phase 1)
Trials (1 total)
Trial APIs (1 total)